Sensex ends 17 points up; Bharti, Sun Pharma shine

September 10, 2012 04:52 pm | Updated 05:43 pm IST - Mumbai

The Sensex today closed 17 points up in lacklustre trade as investors adopted a cautious approach after recent gains and ahead of IIP and inflation data releases later this week.

The BSE benchmark index, which had gained 437 points in last three sessions, shuttled between 17,810.90 and 17,728.12 before ending 17.13 points higher at 17,766.78.

Sun Pharma, Bharti Airtel, CIL and Tata Steel were among the 15 winners in 30-share Sensex, gaining in 1.6-2.6 per cent range. Selling was seen in 14 stocks including Jindal Steel, Bhel and SBI. Sterlite Industries remained unchanged today.

“IIP data will be announced on Sep 12 and inflation numbers will be out on 14th. During the same time, the US Fed will conclude its FOMC meeting. This meeting is closely eyed by market participants across the world,” said Milan Bavishi Head Research, Bonanza Portfolio.

Brokers said some investors also booked profits at existing levels amid worries over further delay in fiscal reforms that might restrict RBI from lowering interest rates.

A better global trend, however, continued to support the domestic shares. The broad-based NSE index Nifty edged up by 4.75 points to 5,363.45, after touching high of 5,375.45.

“Nifty has shown smart recovery from its 50-EMA level after the ECB’s positive outcome on bond-buying program was announced. However, it’ll continue to face stiff resistance near 5400-5450 level in coming sessions,” said Nidhi Sarswat, Senior Research Analyst, Bonanza Portfolio.

Banking stocks led by ICICI Bank and SBI declined ahead of the Reserve Bank of India’s forthcoming mid-quarterly review next week.

Overall, stocks of consumer durables, healthcare, metal and sectors ended higher, while realty, banking, power, FMCG, capital goods and oil and gas sector closed lower.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.